InícioPodcastsThe Long Run with Luke TimmermanEp190: Neil Kumar on Building a Rare Disease Drug CompanyThe Long Run with Luke TimmermanEp190: Neil Kumar on Building a Rare Disease Drug Company20 de novembro de 2025 · 1 h 13 minTocar episódioCompartilhar a partir daquiNotas do episódioNeil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.Todos os episódios de The Long Run with Luke Timmerman